Provider
QP64-25 Commercial Pharmacy Benefit Exclusion for Enflonsia™, Imuldosa™, Osenvelt®, Stoboclo®, Yeztugo® and Zusduri™
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025